ARS Pharmaceuticals Inc (SPRY) poses a Brand-New Opportunity for Investors with beta value of 0.90
As on Wednesday, ARS Pharmaceuticals Inc (NASDAQ: SPRY) started slowly as it slid -5.93% to $14.27, before settling in for the price of $15.17 at
As on Wednesday, ARS Pharmaceuticals Inc (NASDAQ: SPRY) started slowly as it slid -5.93% to $14.27, before settling in for the price of $15.17 at
Witnessing the stock’s movement on the chart, on Thursday, ARS Pharmaceuticals Inc (NASDAQ: SPRY) had a quiet start as it plunged -4.05% to $15.40, before
A new trading day began on Monday, with ARS Pharmaceuticals Inc (NASDAQ: SPRY) stock price up 4.57% from the previous day of trading, before settling
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.